Ask AI
ProCE Banner Activity

IDWeek 2026: What It Means for Latin America

Conference Coverage
Clinical Thought

IDWeek 2026 highlighted important innovations in HIV treatment and prevention. But the success of these innovations will depend on equitable access, sustainable healthcare systems and research that addresses regional priorities. Read on for my perspective on how scientific innovation and effective implementation must advance together to achieve equitable, sustainable, HIV care in Latin America and beyond.

Released: November 19, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Financial Disclosures

Primary Author

Claudia P. Cortes, MD: consultant/advisor/speaker: Gilead, GSK,  MSD, ViiV.